Search Results - "Serody, J.S"

Using RNA Sequencing to Characterize the Tumor Microenvironment by Smith, C C, Bixby, L M, Miller, K L, Selitsky, S R, Bortone, D S, Hoadley, K A, Vincent, B G, Serody, J S

“…RNA sequencing (RNA-seq) is an integral tool in immunogenomics, allowing for interrogation of the transcriptome of a tumor and its microenvironment. Analytical…”
Get more information

Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study by Wood, W A, Deal, A M, Reeve, B B, Abernethy, A P, Basch, E, Mitchell, S A, Shatten, C, Hie Kim, Y, Whitley, J, Serody, J S, Shea, T, Battaglini, C

“…Hematopoietic cell transplantation (HCT) is a life-saving treatment for patients with high-risk hematological malignancies. Prognostic measures to determine…”
Get full text

Efficacy And Safety Of Chemomoblization With VP-16 And G-CSF In Patients (PTS) Undergoing Autologous Stem Cell Transplantation (ASCT) For Multiple Myeloma (MM) by Wood, W.A, Whitley, J.S, Moore, D.T, Sharf, A, Irons, R, Rao, K.V, Serody, J.S, Gabriel, D.A, Coghill, J.M, Shea, T.C

Get full text

The Efficacy And Safety Of VP-16 And G-CSF As A Mobilization Regimen Prior To Autologous Stem Cell Transplantation (ASCT) For Patients (PTS) With Multiple Myeloma (MM) And Lymphoma by Whitley, J.S, Wood, W.A, Moore, D.T, Sharf, A, Irons, R, Rao, K.V, Serody, J.S, Gabriel, D.A, Coghill, J.M, Shea, T.C

Get full text

Predictability And Costs Associated With Good And Poor Mobilizers Using A Combination Of VP-16 And G-CSF For Peripheral Blood Stem Cell (PBSC) Mobilization And Collection by Wood, W.A, Whitley, J.S, Moore, D.T, Sharf, A, Irons, R, Rao, K.V, Serody, J.S, Gabriel, D.A, Coghill, J.M, Shea, T.C

Get full text

Identification of an AUC of 7603 Umol∗Min/Hr Per Day X 4 Days as the Maximum Tolerated Dose (MTD) of IV Continuous Infusion (CI) Busulfan (BU) with Fixed Dose Fludarabine (FLU) in A Pharmacokinetically-Based Dose Phase I Study in Patients (PTS) with Hematologic Malignancies Undergoing Allogeneic Stem Cell Transplantation by Wood, W.A, Walko, C.M, Rao, K.V, Whitley, J, Moore, D.T, Gabriel, D.A, Serody, J.S, Coghill, J.M, Shea, T.C

Get full text

Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT by Wood, W A, Whitley, J, Goyal, R, Brown, P M, Sharf, A, Irons, R, Rao, K V, Essenmacher, A, Serody, J S, Coghill, J M, Armistead, P M, Sarantopoulos, S, Gabriel, D A, Shea, T C

“…The effectiveness of stem cell mobilization with G-CSF in lymphoma patients is suboptimal. We reviewed our institutional experience using chemomobilization…”
Get full text

Ex vivo Inhibition of NF‐κB Signaling in Alloreactive T‐cells Prevents Graft‐Versus‐Host Disease by O'Shaughnessy, M. J., Vogtenhuber, C., Sun, K., Sitcheran, R., Baldwin, A. S., Murphy, W. J., Dang, L., Jaffee, B., Palmer, E., Serody, J. S., Blazar, B. R.

“…The ex vivo induction of alloantigen‐specific hyporesponsiveness by costimulatory pathway blockade or exposure to immunoregulatory cytokines has been shown to…”
Get full text

L‐Selectin Is Dispensable for T Regulatory Cell Function Postallogeneic Bone Marrow Transplantation by Carlson, M. J., Fulton, L. M., Coghill, J. M., West, M. L., Burgents, J. E., Wan, Y., Panoskaltsis‐Mortari, A., Tedder, T. F., Blazar, B. R., Serody, J. S.

“…In murine models, the adoptive transfer of CD4+/CD25+ regulatory T cells (Tregs) inhibited graft‐versus‐host disease (GvHD). Previous work has indicated a…”
Get full text

The role of CD4 +CD25 + T regulatory (T reg) cells in allogeneic bone marrow transplantation by Blazar, B.R., Panoskaltsis-Mortari, A., Levine, B.L., June, C.H., Lucas, P.J., Gress, R., Serody, J.S., Taylor, P.A.

Get full text